Open heart surgery has been performed at the Massachusetts General Hospital in 13 patients less than 6 months after the initiation of treatment for acute or subacute bacterial endocarditis. The endocarditis involved the aortic valve in 12 cases and a mitral valve prosthesis in the other. In two patients there was concomitant rupture of chordae tendineae of the mitral valve. One patient received no preoperative antibiotics, and four were still receiving their initial course of therapy at the time of surgery. The primary indication for surgery in all cases was progressive or intractable congestive heart failure. Ten underwent replacement of the aortic valve alone, two had both aortic and mitral valves replaced, and one had a mitral prosthesis replaced.
Paraprosthetic regurgitation
by prosthetic devices with a high degree of success. There has been understandable reluctance, however, to perform cardiac surgery in the face of active or recently treated endocarditis because of the potential dangers of disseminating residual sepsis and the possibility of its implantation upon the prosthetic device. Nonetheless, in occasional patients, progressive cardiac deterioration has forced surgical intervention despite these hazards. Recently, several reports have appeared describing favorable and even dramatic results of cardiac surgery in such patients.'-"
The purpose of this paper is to describe our experience at the Massachusetts General Hospital with 13 patients who, between 1963 and 1967, underwent cardiac surgery less than 6 months following initiation of antibiotic therapy for bacterial endocarditis. Indications for early surgical intervention in these patients as well as their management before, Circulation, Volume XXXVIII, September 1968 during, and after cardiac surgery are discussed. In all patients surgery was deemed necessary as an urgent lifesaving measure.
Clinical Material and
Results of Surgery Tables 1 and 2 summarize the clinical courses and treatment of these 13 patients. The series includes eight males and five females ranging in age from 26 to 60 years. Eight patients were classified as having subacute bacterial endocarditis on the basis of an indolent course and duration of symptoms of 6 or more weeks prior to treatment. In five the clinical picture was more consistent with acute bacterial endocarditis.
Underlying Heart Disease Nine patients were known to have rheumatic valvular heart disease prior to the onset of bacterial endocarditis. One of these, K. C. (case 9), had previously undergone mitral valve replacement. Four Circulation, Volume XXXVIII, September 1968 patients. One patient (case 13) was felt preoperatively to have aortic regurgitation as a consequence of a dissecting aortic aneurysm rather than bacterial endocarditis and received no antibiotics before operation. Four patients were still receiving their initial course of antibiotics at the time of surgical intervention. The remaining eight were carefully observed following completion of their courses of therapy for signs of recurrent sepsis and every effort was made to allow maximal time for healing of the endocarditis prior to surgery. In treated patients the intervals between initiation of antibiotic treatment and cardiac surgery ranged from 11 days to 5J1 months.
Indications for Surgery
Severe intractable congestive heart failure was present in all patients and represented the primary indication for early surgery. Arterial emboli in two patients (cases 7 and 10), persistent fever (case 5), and recurrent fever after a 4-week course of antibiotics (case 10) were additional indications.
Surgical Procedures
Twelve patients underwent aortic valve replacement. In all cases, surgery was performed through a median sternotomy using cardiopulmonary bypass with coronary perfusion. In two patients (cases 4 figure 1 . This patient was in severe congestive heart failure and virtually moribund at the time of surgery. After aortic valve replacement, improvement was immediate and striking. Now, 2 years after surgery, his heart is normal in size, and he exhibits no evidence of residual cardiac damage. All three deaths occurred during our early operative experience with this problem in 1963 and 1964. Of these, K. K. (case 1) died on the first postoperative day with unresponsive hypotension. At postmortem examination her aortic prosthesis was intact and there was no specific anatomic cause of death. J. C. (case 3) died 1 week after operation from multiple pulmonary emboli. The third death (case 4) occurred 8 months after surgery following chronic congestive heart failure and severe hemolytic anemia associated with murmurs consistent with mitral and aortic paravalvular regurgitation.
Three survivors have developed murmurs consistent with aortic paraprosthetic regurgitation. One of these (case 6) developed gradually increasing cardiomegaly and congestive heart failure and underwent successful repair of the leak 18 months after his original procedure. Another (case 2) recently underwent an uneventful mitral valvulotomy and concomitant repair of a small aortic paraprosthetic defect. In the third (case 10), the leak appears to be hemodynamically insignificant, and he is asymptomatic 17 months after surgery.
Discussion
The prognosis of patients with bacterial endocarditis has improved markedly since the advent of antibiotics with reported 5-year survivals of 50 to 85% in most recent series. 12 Although some patients still succumb to uncontrolled infection, the majority of deaths are related to intractable congestive heart failure resulting from the perforation or destruction of valve leaflets or rupture of chordae tendineae. The The timing of surgical intervention is critical. On the one hand, early surgery is accompanied by the risk that residual sepsis will be disseminated widely or implanted upon the prosthesis. On the other hand, excessive delay may result in irreversible cardiac deterioration. In our patients, all of whom were in severe congestive failure, it was judged that the risks of postponing surgery outweighed those of proceeding with it in the face of recent or active sepsis.
The results of surgery are very encouraging. Ten patients are alive and doing well 6 to 53 months postoperatively. In several, the reversal of rapidly progressive cardiac failure following restoration of hemodynamic competence was dramatic. When intractable heart failure is the primary indication, there seems to be little doubt that surgical intervention can be lifesaving. When the problem is persistent fever, suggesting resistant infection or a myocardial abscess, or recurrent arterial embolization in the absence of severe heart failure, the decision to operate is more difficult. Active or even untreated sepsis need not be an absolute contraindication to surgery as was shown in one of our patients who successfully underwent aortic valve replacement in the face of previously undiagnosed and untreated bacterial endocarditis. The patient K. C. (case 9) 
